CORRELATION OF THE CLINICAL PHARMACODYNAMICS OF LOPRAZOLAM WITH SERUM CONCENTRATION

被引：14

作者：

STEVENS, LA ^{[1
]}

PIDGEN, AW ^{[1
]}

BEVAN, CD ^{[1
]}

INGS, RMJ ^{[1
]}

LAWRENCE, JR ^{[1
]}

MCEWEN, J ^{[1
]}

机构：

[1] HOECHST PHARMACEUT RES LABS,MILTON KEYNES MK7 7AJ,ENGLAND

来源：

XENOBIOTICA | 1985年 / 15卷 / 07期

关键词：

D O I：

10.3109/00498258509045892

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：623 / 631

页数：9

共 31 条

[11] The use of ranks to avoid the assumption of normality implicit in the analysis of variance [J].

Friedman, M .

JOURNAL OF THE AMERICAN STATISTICAL ASSOCIATION, 1937, 32 (200) :675-701

[12]

GREENBLATT DJ, 1981, BRIT J CLIN PHARMACO, V11, pS11

[13]

HINDMARCH I, 1980, DRUG EXP CLIN RES, V6, P125

[14]

HINDMARCH I, 1978, ARZNEIMITTEL-FORSCH, V28, P2169

[15] METABOLISM OF LOPRAZOLAM IN RAT, DOG AND MAN INVIVO [J].

ILLING, HPA ;

BEVAN, CD ;

ROBINSON, JD ;

CHAMBERLAIN, J ;

FROMSON, JM .

XENOBIOTICA, 1983, 13 (09) :539-553

[16] DISPOSITION OF LOPRAZOLAM-C-14 IN ANIMALS AND MAN [J].

ILLING, HPA ;

INGS, RMJ ;

JOHNSON, KI ;

FROMSON, JM .

XENOBIOTICA, 1983, 13 (07) :439-449

[17] METABOLISM OF LOPRAZOLAM IN RAT-LIVER AND DOG-LIVER PREPARATIONS [J].

ILLING, HPA ;

WATSON, KV ;

CHAMBERLAIN, J .

XENOBIOTICA, 1983, 13 (09) :531-538

[18]

JOHNS TG, 1979, ARCH INT PHARMACOD T, V240, P53

[19] HUMAN PHARMACOKINETICS OF NITRAZEPAM - EFFECT OF AGE AND DISEASES [J].

KANGAS, L ;

IISALO, E ;

KANTO, J ;

LEHTINEN, V ;

PYNNONEN, S ;

RUIKKA, I ;

SALMINEN, J ;

SILLANPAA, M ;

SYVALAHTI, E .

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1979, 15 (03) :163-170

[20]

KORTTILA K, 1977, ACTA PHARMACOL TOX, V40, P241

← 1 2 3 4 →